ALK and neuroblastoma: However, a large-scale analysis of the spectrum of ALK mutations, their clinical significance, and their biochemical properties in NB is essential to direct preclinical and clinical studies of ALK inhibitors and to identify patients likely to benefit from ALK inhibition in NB.